|
|
1450 Infinite Drive Louisville, CO 80027 USA phone:303.625.2700 fax:303.625.2710
|
|
| Symbol |
Private |
| Founded |
1995 |
| Employees |
54 |
|
|
| www.globeimmune.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Developing vaccines to treat human diseases such as HIV and cancer. |
 |
| Management |
| Kirk Christoffersen, MBA, Senior Director Corporate Development; Claire Coeshott, Ph.D., Director, Imunology; Jeffrey Dekker, Senior Director, Finance & Controller; April Duffey, SPHR, Senior Director, Human Resources; John Ferraro, MBA, CCRA, Senior Director, Clinical Operations |
| |
|
|
| |
|
| Keywords |
| saccharomyces, tarmogens, globeimmune, immune, lymphocytes |
|
|
|
| Description |
|
GlobeImmune Inc.'s mission is to revolutionize healthcare through its proprietary vaccine technologies. The Company is designing vaccines with the unprecedented ability to prevent and treat human diseases such as HIV and cancers, leading to higher quality of life and lower overall healthcare costs. |
 |
| Products / Services |
The company's lead oncology program, GI-4000, targets cancers caused by mutated versions of the Ras oncoprotein. GI-4000 is being investigated in clinical trials for the treatment of pancreas cancer as well as other cancers that contain mutated Ras, including non-small cell lung cancer and colorectal cancer. The company's lead infectious disease program, GI-5005, is a Tarmogen for the treatment of chronic hepatitis C infection (HCV). GI-5005 is designed to complement both the current standard of care and emerging novel therapies for HCV.
|
 |
| Technology / Differentiation |
| Tarmogens are whole, heat-killed recombinant Saccharomyces cerevisiae yeast genetically modified to express one or more protein targets that stimulate the immune system against diseased cells. Tarmogens are avidly taken up by the cells that activate the immune system called antigen presenting cells, to stimulate so called "killer T cells" directed against the desired target. |
 |
 |
|
|
|
|
|
|